Dr. Martin Makary testifies during his confirmation hearing before the Senate Committee on Health, Education, Labor, and Pensions Committee on March 06, 2025, in Washington, DC. This story was ...
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative ...
Geriatrics and Aging. 2005;8(6):43-45. Is the treatment still indicated or has the diagnosis been refuted? For example, a putative diagnosis of angina may have subsequently been disproved. Treatments ...
CHMP is reviewing avacopan, a drug authorized in the EU for treating adults with severe, active granulomatosis with polyangiitis or microscopic polyangiitis.
WASHINGTON — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the agency, ...
People with type 2 diabetes who receive comprehensive medication reviews (CMRs) had better adherence with oral antidiabetic drugs and statin utilization compared to those who did not receive CMRs, a ...
A new California law will require pharmacist-led medication reviews for high-risk hospital patients at discharge starting Jan. 1, according to a Cedars-Sinai news release. The law, promoted by ...
Pharmacist-led medication reviews cut drug complications in half for older adults with hip fractures
A study found that clinical pharmacist-led reviews of hospital medications for older adults with hip fractures were linked to significantly lower rates of adverse drug reactions (ADRs). The research, ...
WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting “the health interests of Americans,” under a new initiative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results